VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
CME
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CMECME Group Inc.
$267.88$96.3B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCMEBalance Sheet

CME Group Inc. (CME) Balance Sheet

26Y historyFree accessUpdated daily

Total assets surged 41% year-over-year to $194.7B, driven by a $38B increase in performance bond deposits, but equity remained flat at $26.5B, causing the equity-to-assets ratio to fall to 13.6% from 20.6% a year earlier.

CME Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Cash & Short Term Investments11.91B4.55B3.01B3.02B2.82B2.95B1.73B1.63B1.45B1.99B1.95B1.77B1.44B2.54B1.66B10.42B4.94B6.29B607.97M1.05B3.87B3.66B747.51M812.17M3.15B1.9B30.66M
Cash & Due from Banks2.14B4.42B2.89B2.91B2.72B2.83B1.63B1.55B1.37B1.9B1.87B1.69B1.37B2.47B1.6B1.04B855.2M260.6M297.89M845.31M969.5M610.89M357.56M185.12M339.26M69.1M30.66M
Short Term Investments131.4M125M113.2M111.7M96M115M100.9M83.2M72.9M90.1M83.3M72.5M74.7M68.4M56.6M9.38B4.09B6.02B310.08M203.31M2.9B3.05B389.95M627.04M2.81B1.83B0
Total Investments131.4M1.63B113.2M111.7M96M115M100.9M83.2M72.9M90.1M83.3M72.5M74.7M68.4M56.6M47.6M4.09B6.02B310.1M203.31M2.9B3.05B389.95M627.04M2.81B1.83B0
Investments Growth %1366.44%1335.95%1.34%16.35%-16.52%13.97%21.27%14.13%-19.09%8.16%14.9%-2.95%9.21%20.85%18.91%-98.84%-32.13%1842.76%52.53%-92.99%-4.72%681.1%-37.81%-77.71%53.8%--
Long-Term Investments1.5B1.5B0000000000000000000000000
Accounts Receivables753.1M639.2M573.1M535.6M483.2M434.5M461.3M491.8M553.3M359.7M364.4M357.8M341.2M302.7M267.5M289.4M297.5M248.3M234M187.49M121.13M86.98M78.83M52.97M50.87M40.99M28.53M
Goodwill & Intangibles27.68B30.3B30.48B30.72B30.93B31.24B32.84B33.04B33.48B27.09B27.19B27.28B27.38B27.49B27.6B28.34B28.48B27.78B27.87B14.83B24.27M000000
Goodwill10.51B10.51B10.49B10.5B10.48B10.53B10.8B10.74B10.81B7.57B7.57B7.57B7.57B7.57B7.57B7.98B7.98B7.55B7.52B5.05B11.5M000000
Intangible Assets17.18B19.79B20B20.23B20.45B20.71B22.04B22.29B22.68B19.52B19.62B19.71B19.81B19.92B20.03B20.35B20.49B20.23B20.35B9.78B12.78M000000
PP&E (Net)351.2M573M386.2M409.5M455.5M505.3M579.2M544M448.7M399.7M425.2M491.7M508.9M513.4M724M821.9M786.8M738.5M707.2M377.45M168.75M153.33M131.36M118.2M109.56M100.99M80.39M
Other Assets5.01B160.86B3.54B3.69B3.71B3.28B1.96B2.07B1.66B1.39B1.73B1.68B1.81B1.87B1.83B653.7M394.4M435.8M469.4M108.69M52.28M32.64M31.24M31.05M30.32M19.78M33.62M
Total Current Assets161.63B5.19B103.03B94.89B139.08B161.76B89.28B39.57B41.89B46.91B40.03B37.9B42.55B24.41B8.72B10.95B5.39B6.7B19.11B4.99B4.03B3.78B2.69B4.72B3.22B1.95B267.43M
Total Non-Current Assets33.05B193.36B34.41B34.82B35.1B35.02B35.38B35.65B35.59B28.88B29.34B29.45B29.7B29.87B30.15B29.81B29.66B28.95B29.05B15.32B276.25M185.97M162.6M149.26M139.88M120.77M114.01M
Total Assets194.68B198.55B137.45B129.71B174.18B196.78B124.66B75.22B77.48B75.79B69.37B67.36B72.24B54.28B38.86B40.76B35.05B35.65B48.16B20.31B4.31B3.97B2.86B4.87B3.36B2.07B381.44M
Asset Growth %116.46%44.45%5.97%-25.53%-11.49%57.85%65.74%-2.92%2.22%9.26%2.98%-6.76%33.1%39.66%-4.65%16.3%-1.7%-25.97%137.16%371.52%8.49%38.91%-41.36%45.23%62.32%441.86%-
Return on Assets (ROA)2.18%2.41%2.64%2.12%1.45%1.64%2.11%2.77%2.56%5.6%2.24%1.79%1.78%2.1%2.25%4.78%2.69%1.97%2.09%5.35%9.84%8.99%5.68%2.97%3.47%5.58%-1.55%
Accounts Payable68M71.8M79.9M90.6M121.4M48.8M69.3M61.9M116M31.3M26.2M28.7M36.9M36.2M41.7M31.1M51.8M46.7M71M58.97M25.55M23.55M23.05M24.69M27.61M23.83M11.9M
Total Debt3.42B3.76B3.43B3.43B3.44B3.45B3.44B3.74B4.4B46.42B39.77B37.78B42.67B2.86B2.86B11.44B2.53B2.31B3.22B164.44M521.18M001.51M2.33M6.65M6.06M
Net Debt1.28B-666.2M535.6M513.4M718.3M610.2M1.81B2.19B3.03B44.51B37.91B36.09B41.31B387.4M1.25B10.4B1.67B2.05B2.92B-680.88M-448.32M-610.89M-357.56M-183.61M-336.93M-62.45M-24.59M
Long-Term Debt3.42B3.42B2.68B3.43B3.42B2.7B3.44B3.74B3.83B2.23B2.23B2.23B2.11B2.11B2.11B2.11B2.1B2.01B2.97B000002.33M6.65M6.06M
Short-Term Debt055.8M749.8M016M749.4M00574.2M44.19B37.54B35.55B40.57B749.9M749.7M9.33B420.5M299.8M249.9M164.44M521.18M001.51M000
Other Liabilities793.8M160.7B721.2M798.2M826M896.5M1.06B1.16B745.1M615.7M560.9M395.5M376.2M449.4M220.5M187.6M191.5M165.8M132.7M76.26M32.06M20.78M19.25M21.67M17.05M10.02M13.42M
Total Current Liabilities158.79B55.8M102.31B93.42B137.69B160.4B88.2B38.52B41.27B45.67B38.95B36.82B41.53B23.31B7.62B9.62B4.78B6.52B18.64B4.08B2.76B2.83B2.03B4.29B2.89B1.8B198.29M
Total Non-Current Liabilities9.44B169.76B8.65B9.55B9.61B8.98B10.11B10.53B10.24B7.71B10.08B9.98B9.79B9.81B9.74B9.52B10.14B9.83B10.83B3.92B32.06M20.78M19.25M21.67M19.38M16.67M19.48M
Total Liabilities168.22B169.82B110.96B102.97B147.3B169.38B98.31B49.06B51.51B53.38B49.03B46.81B51.32B33.12B17.36B19.14B14.92B16.35B29.47B8B2.79B2.85B2.04B4.31B2.91B1.82B217.77M
Total Equity26.52B28.73B26.49B26.74B26.88B27.4B26.35B26.16B25.97B22.41B20.34B20.55B20.92B21.16B21.51B21.62B20.13B19.3B18.69B12.31B1.52B1.12B812.6M563M446.14M248.37M163.67M
Equity Growth %2.45%8.46%-0.94%-0.52%-1.9%3.98%0.73%0.75%15.86%10.18%-1.03%-1.78%-1.12%-1.61%-0.54%7.42%4.29%3.28%51.87%710.07%35.79%37.67%44.33%26.19%79.63%51.75%-
Equity / Assets (Capital Ratio)13.62%14.47%19.27%20.61%15.43%13.92%21.14%34.78%33.51%29.57%29.32%30.51%28.96%38.99%55.34%53.05%57.43%54.14%38.81%60.6%35.27%28.18%28.44%11.55%13.3%12.02%42.91%
Return on Equity (ROE)15.53%14.65%13.25%12.03%9.92%9.81%8.02%8.12%8.11%19.01%7.5%6.01%5.36%4.58%4.16%8.68%4.83%4.35%4.62%9.53%30.89%31.78%31.92%24.21%27.09%33.15%-3.61%
Book Value per Share73.2179.7573.5974.3874.8376.3473.5073.0275.5465.8760.0160.8262.2663.2864.7164.7760.5458.0163.3955.808.656.424.723.322.971.701.14
Tangible BV per Share-3.20-4.37-11.10-11.08-11.27-10.69-18.10-19.19-21.86-13.75-20.19-19.92-19.22-18.91-18.33-20.12-25.11-25.48-31.14-11.468.516.424.723.322.971.701.14
Common Stock3.6M3.6M3.6M3.6M3.6M3.6M3.6M3.6M3.6M3.4M3.4M3.4M3.4M3.3M3.3M3.3M700K700K700K533K348K345K341K329K325K288K288K
Additional Paid-in Capital022.21B22.4B22.33B22.26B22.19B21.19B21.11B21.05B17.9B17.83B17.72B17.6B17.5B17.21B17.11B17.28B17.19B17.13B10.69B405.51M324.85M261.05M195.22M179.67M59.23M43.88M
Retained Earnings5.46B6.43B4.19B4.46B4.75B5.15B5B5.01B4.86B4.5B2.52B2.91B3.32B3.49B3.99B4.32B2.89B2.24B1.72B1.62B1.12B796.4M552.8M368.31M266.81M190.03M119.51M
Accumulated OCI54.9M81.9M-105.5M-55.6M-133.3M53.5M134.9M3.4M5.3M14.3M-14.1M-80.8M6.2M152M209.3M111.6M-104.1M-126.2M-160.3M-3.1M-2.98M-2.91M-1.59M-868K-665K-1.18M-11K
Treasury Stock000000000000000000000000000
Preferred Stock000000000000000000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

FMX competition and EPS miss

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Asset Growth Driven by Collateral Inflows

Total assets surged 41% year-over-year to $194.7B in Q2 2026, according to reported figures, driven primarily by a $38B increase in performance bond deposits, reflecting record trading volumes.

The balance sheet expansion is almost entirely attributable to growth in clearinghouse collateral liabilities, not organic asset accumulation. Equity remained flat at $26.5B, indicating that the asset growth is liability-funded and does not represent capital deployment. This pattern suggests the balance sheet is a byproduct of market activity rather than a strategic growth driver, with the equity-to-assets ratio compressing to 13.6% from 20.6% a year earlier.

Collateral Balances Drive Interest Income

Performance bond deposits, akin to non-interest-bearing deposits, reached $168.2B in Q2 2026, as per financial statements, enabling CME to earn $43.6M in net interest income, a swing from negative NII in prior quarters.

CME's 'deposit franchise' is unique: it holds collateral from clearing members, which are non-interest-bearing liabilities. The recent positive NII suggests that CME is now earning more on these balances than it pays in interest, likely due to higher short-term rates. However, this income stream is volatile and dependent on rate levels and collateral composition, warranting monitoring for sustainability.

Provision Spike Raises Credit Questions

Provision for credit losses jumped to $568.3M in Q2 2026 from $179.4M in Q1, based on reported figures, a level not seen in prior quarters, suggesting a potential one-time charge or reserve build.

While CME does not have a traditional loan book, the provision spike is notable. It may relate to credit losses on clearinghouse default fund contributions or other financial assets. The increase could indicate a deterioration in the credit quality of clearing members or a conservative reserve build. Investors should monitor whether this is a one-time event or a trend, as it directly impacts earnings.

Equity Flat Despite Record Volumes

Equity remained essentially flat at $26.5B in Q2 2026, as reported in financial statements, with the equity-to-assets ratio falling to 13.6% from 20.6% a year earlier, reflecting liability-driven asset growth.

CME's capital position appears stable in absolute terms, but the declining equity-to-assets ratio is a function of collateral inflows, not a deterioration in capital strength. The company's regulatory capital requirements are based on risk-weighted assets, which are not disclosed here. The flat equity suggests that earnings are being returned to shareholders via dividends, consistent with the variable dividend policy.

Liquidity Relies on Collateral, Not Core Deposits

Cash and bank balances totaled $2.1B in Q2 2026, according to reported figures, while investment securities were minimal at $131.4M, indicating that CME's liquidity is primarily derived from its role as a clearinghouse rather than traditional banking assets.

CME's liquidity profile is atypical for a financial institution. The company does not rely on wholesale funding or core deposits; instead, it holds performance bond collateral that is returned to clearing members. The low levels of cash and securities suggest that CME operates with minimal liquidity risk, but also that it does not generate significant interest income from a large investment portfolio. The recent positive NII is a positive development, but its magnitude is small relative to total revenue.

Collateral Interest Rate Sensitivity

Net interest income swung from negative to positive in Q2 2026, as per financial statements, but this is highly sensitive to interest rate changes on performance bond deposits, which could reverse if rates decline.

The most non-obvious risk is the interest rate sensitivity of the collateral balances. CME earns interest on the float of performance bond deposits, but if rates fall, this income could diminish or turn negative again. Additionally, the provision spike in Q2 may indicate credit risk in the clearinghouse default fund, which is not fully transparent. Investors should monitor the composition of collateral and the potential for credit losses in stressed market conditions.

CME — Frequently Asked Questions

Quick answers to the most common questions about buying CME stock.

What are the total assets of CME Group Inc. (CME)?

As of 2025, CME Group Inc. (CME) had total assets of $198.55B including $5.19B in current assets.

How much debt does CME Group Inc. (CME) have?

CME Group Inc. (CME) carries total debt of $3.76B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of CME Group Inc.?

CME Group Inc. (CME) has total shareholders' equity (book value) of $28.73B ($79.75 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is CME Group Inc.'s current ratio and liquidity?

CME Group Inc. (CME) reported a current ratio of 92.97x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.